APOL1-nephropathy has incomplete penetrance, with an estimated 15% lifetime risk for those with a high-risk genotype developing end-stage kidney disease (ESKD), suggesting there are non-genetic factors that modify risk (Dummer et al., 2015). The gene discussed is APOL1; the disease is kidney disorder.